Liquid Markers Should Precede Imaging in Pre-prostate Biopsy Decision-making: Con

Eur Urol Focus. 2022 Jul;8(4):895-896. doi: 10.1016/j.euf.2022.08.003. Epub 2022 Aug 22.

Authors

Eder S Brazao Jr¹, Hashim U Ahmed²

Affiliations

¹ Imperial Prostate, Imperial College London, London, UK. Electronic address: ederbrazaojr@gmail.com.
² Imperial Prostate, Imperial College London, London, UK. Electronic address: hashim.ahmed@imperial.ac.uk.

PMID: 36008244
DOI: 10.1016/j.euf.2022.08.003

Abstract

Liquid biomarkers have not yet reached the level of evidence to replace magnetic resonance imaging in the prebiopsy pathway for prostate cancer.

Crown Copyright © 2022. Published by Elsevier B.V. All rights reserved.

MeSH terms

Biomarkers
Biopsy
Humans
Magnetic Resonance Imaging
Male
Prostate* / diagnostic imaging
Prostate* / pathology
Prostatic Neoplasms* / diagnostic imaging
Prostatic Neoplasms* / pathology

Substances

Biomarkers